Sensus Healthcare
SRTS
67 hedge funds and large institutions have $25.5M invested in Sensus Healthcare in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 23 reducing their positions, and 12 closing their positions.
15% more call options, than puts
Call options by funds: $284K | Put options by funds: $246K
0% more funds holding
Funds holding: 67 → 67 (0)
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
0.69% less ownership
Funds ownership: 30.56% → 29.88% (-0.69%)
9% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 23
29% less capital invested
Capital invested by funds: $36.2M → $25.5M (-$10.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.33M |
| 2 |
Renaissance Technologies
New York
|
+$699K |
| 3 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$431K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$430K |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
+$393K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIPM
G2 Investment Partners Management
New York
|
-$1.1M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$751K |
| 3 |
NA
Navellier & Associates
Reno,
Nevada
|
-$526K |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
-$481K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$465K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Belvedere Trading
Chicago,
Illinois
| – | -$58.7K | -7,912 | Closed |
|
77
BNP Paribas Financial Markets
Paris,
France
| – | -$24.8K | -3,345 | Closed |
|
|
CG
78
Cutler Group
San Francisco,
California
| – | -$5.09K | -709 | -88% |
|
|
PTC
79
Private Trust Company
Cleveland,
Ohio
| – | -$3K | -400 | Closed |
|
SRTS Hedge Fund Activity: Q1 2023 in Review
67 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Sensus Healthcare (SRTS) for Q1 2023, worth a combined $25.5M — down 29% from $36.2M a quarter earlier.
Fund positioning in SRTS was balanced in Q1 2023: 12 funds opened new positions, 12 closed out, 21 added to existing stakes and 23 trimmed.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $1.33M. The largest seller was G2 Investment Partners Management, exiting entirely with an estimated $1.1M sold.
- 67 institutional investors held Sensus Healthcare (SRTS) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $25.5M of Sensus Healthcare stock for Q1 2023, down 29% quarter-over-quarter.
- 12 funds opened new Sensus Healthcare positions in Q1 2023 and 12 closed out, a net change of 0 holders.
- The largest Sensus Healthcare buyer in Q1 2023 was Nantahala Capital Management, an estimated $1.33M added.
- The largest Sensus Healthcare seller in Q1 2023 was G2 Investment Partners Management, an estimated $1.1M sold.
Based on aggregated 13F filings for Q1 2023.